Literature DB >> 6935668

Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.

U Lindahl, G Bäckström, L Thunberg, I G Leder.   

Abstract

An octasaccharide with high affinity for antithrombin was isolated after partial deaminative cleavage of heparin with nitrous acid. After conversion of the 2,5-anhydro-D-mannose end group to anhydro[1-3H]mannitol, labeled pentasaccharide was released from the octasaccharide by periodate-alkali treatment. Incubation of the pentasaccharide with a recently discovered 3,O-sulfatase from human urine resulted in desulfation, suggesting the occurrence of a 3-sulfate group on the terminal glucosamine residue. The same glucosamine residue was recovered as a 2,5-anhydro[1-3H]mannitol derivative by a procedure involving deamination of the octasaccharide with nitrous acid, reduction of the products with sodium boro[3H]hydride, isolation of 3H-labeled tetrasaccharide by gel chromatography, and release of the labeled end-group by periodate-alkali treatment. Paper electrophoresis indicated disulfated anhydro[3H]mannitol, presumably sulfated at C3 and C6, as a major component, along with smaller amounts of monosulfated (presumably 3-sulfated) anhydro[3H]mannitol. Similar treatment of an analogous tetrasaccharide derived from heparin with low affinity for antithrombin failed to produce any disulfated anhydromannitol. These results suggest that 3-sulfated glucosamine is a unique component of high-affinity heparin, located at a specific position in the antithrombin-binding sequence of the molecule.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6935668      PMCID: PMC350323          DOI: 10.1073/pnas.77.11.6551

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration.

Authors:  L O Andersson; T W Barrowcliffe; E Holmer; E A Johnson; G E Sims
Journal:  Thromb Res       Date:  1976-12       Impact factor: 3.944

2.  The separation of active and inactive forms of heparin.

Authors:  L H Lam; J E Silbert; R D Rosenberg
Journal:  Biochem Biophys Res Commun       Date:  1976-03-22       Impact factor: 3.575

3.  Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin.

Authors:  M Höök; I Björk; J Hopwood; U Lindahl
Journal:  FEBS Lett       Date:  1976-07-01       Impact factor: 4.124

4.  Formation of anhydrosugars in the chemical depolymerization of heparin.

Authors:  J E Shively; H E Conrad
Journal:  Biochemistry       Date:  1976-09-07       Impact factor: 3.162

5.  Investigations on the chemistry of heparin. VI. Position of the sulfate ester groups.

Authors:  I Danishefsky; H Steiner; A Bella; A Friedlander
Journal:  J Biol Chem       Date:  1969-04-10       Impact factor: 5.157

Review 6.  Chemistry of the hemostatic mechanism and its relationship to the action of heparin.

Authors:  R D Rosenberg
Journal:  Fed Proc       Date:  1977-01

7.  Correlation between structure and function of heparin.

Authors:  R D Rosenberg; L Lam
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

8.  Biosynthesis of heparin. Loss of C-5 hydrogen during conversion of D-glucuronic to L-iduronic acid residues.

Authors:  U Lindahl; I Jacobsson; M Höök; G Backström; D S Feingold
Journal:  Biochem Biophys Res Commun       Date:  1976-05-17       Impact factor: 3.575

9.  Identification of N-sulphated disaccharide units in heparin-like polysaccharides.

Authors:  I Jacobsson; M Höök; I Pettersson; U Lindahl; O Larm; E Wirén; K von Figura
Journal:  Biochem J       Date:  1979-04-01       Impact factor: 3.857

10.  Solvolytic desulfation of glycosaminoglycuronan sulfates with dimethyl sulfoxide containing water or methanol.

Authors:  K Nagasawa; Y Inoue; T Kamata
Journal:  Carbohydr Res       Date:  1977-09       Impact factor: 2.104

View more
  104 in total

1.  Insights into the role of 3-O-sulfotransferase in heparan sulfate biosynthesis.

Authors:  Maria Cecília Zorél Meneghetti; Tarsis Gesteira Ferreira; Alexandre Keiji Tashima; Suely F Chavante; Edwin Alexander Yates; Jian Liu; Helena Bonciani Nader; Marcelo A Lima
Journal:  Org Biomol Chem       Date:  2017-08-16       Impact factor: 3.876

2.  Structural characterization of heparins from different commercial sources.

Authors:  Fuming Zhang; Bo Yang; Mellisa Ly; Kemal Solakyildirim; Zhongping Xiao; Zhenyu Wang; Julie M Beaudet; Amanda Y Torelli; Jonathan S Dordick; Robert J Linhardt
Journal:  Anal Bioanal Chem       Date:  2011-09-20       Impact factor: 4.142

Review 3.  Intracellular proteoglycans.

Authors:  Svein Olav Kolset; Kristian Prydz; Gunnar Pejler
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

Review 4.  Limitations of conventional anticoagulant therapy and the promises of non-heparin based conformational activators of antithrombin.

Authors:  Qudsia Rashid; Poonam Singh; Mohammad Abid; Mohamad Aman Jairajpuri
Journal:  J Thromb Thrombolysis       Date:  2012-08       Impact factor: 2.300

5.  Cell mutants defective in synthesizing a heparan sulfate proteoglycan with regions of defined monosaccharide sequence.

Authors:  A L De Agostini; H K Lau; C Leone; H Youssoufian; R D Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

6.  Controlled Chemoenzymatic Synthesis of Heparan Sulfate Oligosaccharides.

Authors:  Weigang Lu; Chengli Zong; Pradeep Chopra; Lauren E Pepi; Yongmei Xu; I Jonathan Amster; Jian Liu; Geert-Jan Boons
Journal:  Angew Chem Int Ed Engl       Date:  2018-03-30       Impact factor: 15.336

7.  Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin.

Authors:  B Bray; D A Lane; J M Freyssinet; G Pejler; U Lindahl
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

Review 8.  Mice deficient in heparan sulfate 3-O-sulfotransferase-1: normal hemostasis with unexpected perinatal phenotypes.

Authors:  Nicholas W Shworak; Sassan HajMohammadi; Ariane I de Agostini; Robert D Rosenberg
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

9.  Modular synthesis of heparan sulfate oligosaccharides for structure-activity relationship studies.

Authors:  Sailaja Arungundram; Kanar Al-Mafraji; Jinkeng Asong; Franklin E Leach; I Jonathan Amster; Andre Venot; Jeremy E Turnbull; Geert-Jan Boons
Journal:  J Am Chem Soc       Date:  2009-12-02       Impact factor: 15.419

10.  Unique extracellular matrix heparan sulfate from the bivalve Nodipecten nodosus (Linnaeus, 1758) safely inhibits arterial thrombosis after photochemically induced endothelial lesion.

Authors:  Angélica M Gomes; Eliene O Kozlowski; Vitor H Pomin; Cintia Monteiro de Barros; José L Zaganeli; Mauro S G Pavão
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.